Inhibitors of histone lysine specific demethylase (lsd1) and histone deacetylases (hdacs)
US-2021009511-A1 · Jan 14, 2021 · US
Compounds and methods of treating obesity
US9428448B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9428448-B2 |
| Application number | US-201414314228-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 25, 2014 |
| Priority date | Mar 4, 2008 |
| Publication date | Aug 30, 2016 |
| Grant date | Aug 30, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided are new fatty acid derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, e.g., as agents for the treatment of obesity and related disorders, and for improving cognition.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for treating or reducing the severity of obesity, increasing or facilitating weight loss, suppressing, inhibiting or reducing appetite, decreasing food consumption, or improving cognitive function in a subject, comprising: administering to a subject in need thereof a compound selected from the group consisting of 2. A method for suppressing, inhibiting or reducing appetite, decreasing food consumption, or improving cognitive function in a subject, comprising: administering to a subject in need thereof a formula 10: 3. The method of claim 1 , for treating obesity in a subject. 4. The method of claim 1 , for increasing or facilitating weight loss in a subject. 5. The method of claim 1 , for suppressing, inhibiting or reducing appetite in a subject.
Assignees
Inventors
Classifications
having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms · CPC title
the carbon skeleton being acyclic and unsaturated · CPC title
- C07C271/02Primary
Carbamic acids; Salts of carbamic acids (unsubstituted carbamic acid or salts thereof C01B21/12) · CPC title
Acids containing more than four carbon atoms · CPC title
Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof (thiurams A61K31/145) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9428448B2 cover?
- Provided are new fatty acid derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, e.g., as agents for the treatment of obesity and related disorders, and for improving cognition.
- Who is the assignee on this patent?
- Yissum Res Dev Co, Al-Quds Univ
- What technology area does this patent fall under?
- Primary CPC classification C07C271/02. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).